Coston McIsaac & Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
259
| – | – | ﹤0.01% | 639 |
|
|
2025
Q1 | $3K | Hold |
259
| – | – | ﹤0.01% | 653 |
|
|
2024
Q4 | $3K | Hold |
259
| – | – | ﹤0.01% | 650 |
|
|
2024
Q3 | $3 | Hold |
259
| – | – | ﹤0.01% | 664 |
|
|
2024
Q2 | $3K | Hold |
259
| – | – | ﹤0.01% | 638 |
|
|
2024
Q1 | $3K | Sell |
259
-7
| -3% | -$81 | ﹤0.01% | 633 |
|
|
2023
Q4 | $3K | Hold |
266
| – | – | ﹤0.01% | 630 |
|
|
2023
Q3 | $4K | Hold |
266
| – | – | ﹤0.01% | 590 |
|
|
2023
Q2 | $4K | Hold |
266
| – | – | ﹤0.01% | 636 |
|
|
2023
Q1 | $4K | Hold |
266
| – | – | ﹤0.01% | 625 |
|
|
2022
Q4 | $4 | Hold |
266
| – | – | ﹤0.01% | 626 |
|
|
2022
Q3 | $3K | Hold |
266
| – | – | ﹤0.01% | 574 |
|
|
2022
Q2 | $4K | Buy |
+266
| New | +$4K | ﹤0.01% | 378 |
|